Truist Financial Cuts Cognex (NASDAQ:CGNX) Price Target to $42.00

Cognex (NASDAQ:CGNX) had its price target reduced by Truist Financial from $45.00 to $42.00 in a research report report published on Thursday, MarketBeat reports. They currently have a hold rating on the scientific and technical instruments company’s stock.

Other equities research analysts have also issued research reports about the company. Barclays reissued an “overweight” rating and set a $56.00 price target (up previously from $55.00) on shares of Cognex in a research note on Friday, October 31st. JPMorgan Chase & Co. reissued an “underweight” rating and issued a $35.00 target price (down previously from $45.00) on shares of Cognex in a report on Wednesday, December 3rd. KeyCorp restated an “overweight” rating and issued a $50.00 price target on shares of Cognex in a research report on Friday, October 31st. The Goldman Sachs Group upgraded shares of Cognex from a “sell” rating to a “buy” rating and boosted their price objective for the stock from $42.00 to $50.00 in a research report on Tuesday. Finally, DA Davidson set a $38.00 price objective on shares of Cognex and gave the company a “neutral” rating in a research note on Monday, November 3rd. Nine investment analysts have rated the stock with a Buy rating, seven have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock has a consensus rating of “Hold” and a consensus target price of $45.79.

Cognex Stock Performance

Shares of CGNX opened at $36.80 on Thursday. The stock has a market capitalization of $6.17 billion, a PE ratio of 57.50 and a beta of 1.53. Cognex has a 1 year low of $22.67 and a 1 year high of $49.76. The company’s 50-day simple moving average is $40.18 and its 200-day simple moving average is $39.30.

Cognex (NASDAQ:CGNX) last announced its quarterly earnings results on Wednesday, October 29th. The scientific and technical instruments company reported $0.33 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.27 by $0.06. The business had revenue of $264.00 million during the quarter, compared to the consensus estimate of $261.86 million. Cognex had a net margin of 11.33% and a return on equity of 8.26%. The business’s revenue was up 18.0% compared to the same quarter last year. During the same quarter last year, the firm posted $0.20 EPS. Cognex has set its Q4 2025 guidance at 0.190-0.24 EPS. On average, sell-side analysts predict that Cognex will post 0.61 earnings per share for the current year.

Cognex Increases Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, November 28th. Shareholders of record on Thursday, November 13th were issued a $0.085 dividend. This is a positive change from Cognex’s previous quarterly dividend of $0.08. The ex-dividend date was Thursday, November 13th. This represents a $0.34 dividend on an annualized basis and a yield of 0.9%. Cognex’s payout ratio is currently 53.13%.

Insider Activity at Cognex

In other news, Director Robert Willett sold 6,704 shares of the business’s stock in a transaction that occurred on Tuesday, October 21st. The shares were sold at an average price of $49.51, for a total value of $331,915.04. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 1.60% of the stock is currently owned by company insiders.

Institutional Trading of Cognex

Hedge funds and other institutional investors have recently bought and sold shares of the company. Nuveen LLC acquired a new stake in shares of Cognex during the first quarter worth $12,064,000. HighTower Advisors LLC lifted its position in Cognex by 6.7% during the first quarter. HighTower Advisors LLC now owns 23,139 shares of the scientific and technical instruments company’s stock worth $690,000 after buying an additional 1,461 shares during the period. Algert Global LLC boosted its stake in Cognex by 16.6% in the 1st quarter. Algert Global LLC now owns 95,387 shares of the scientific and technical instruments company’s stock worth $2,845,000 after buying an additional 13,590 shares during the last quarter. Hsbc Holdings PLC grew its holdings in Cognex by 813.1% in the 1st quarter. Hsbc Holdings PLC now owns 120,964 shares of the scientific and technical instruments company’s stock valued at $3,575,000 after buying an additional 107,716 shares during the period. Finally, Capital Fund Management S.A. increased its stake in shares of Cognex by 115.5% during the 1st quarter. Capital Fund Management S.A. now owns 167,787 shares of the scientific and technical instruments company’s stock valued at $5,005,000 after acquiring an additional 89,933 shares during the last quarter. 88.12% of the stock is owned by hedge funds and other institutional investors.

Cognex Company Profile

Cognex Corporation is a leading provider of machine vision systems, software, sensors and industrial barcode readers used to automate manufacturing, logistics and distribution processes. The company designs and develops vision-based products that help manufacturers and logistics operators inspect, identify and guide parts, assemblies and packaged goods in real time. Its solutions are applied in a broad range of industries, including automotive, electronics, semiconductor, pharmaceutical, food and beverage, and general manufacturing.

The company’s product portfolio includes stand-alone vision systems, vision sensors and deep learning-based software platforms that enable automated inspection, quality control and traceability.